BioXcel Therapeutics (BTAI) Prepaid Assets (2017 - 2026)

BioXcel Therapeutics' Prepaid Assets history runs 10 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• On a quarterly basis, Prepaid Assets fell 16.72% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $3.9 million, a 16.72% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 23.86% from the prior year.
• Prepaid Assets declined to $3.9 million in Q1 2026 per BTAI's latest filing, from $4.0 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $5.3 million in Q4 2024 and bottomed at $934000.0 in Q3 2025.
• The 5-year median for Prepaid Assets is $3.9 million (2023), against an average of $3.4 million.
• Across the five-year window, Prepaid Assets jumped 220.82% in 2022 and sank 63.72% in 2024, its largest moves.
• Year by year, Prepaid Assets stood at $3.1 million in 2022, then plunged by 32.25% to $2.1 million in 2023, then surged by 154.57% to $5.3 million in 2024, then dropped by 23.86% to $4.0 million in 2025, then retreated by 2.06% to $3.9 million in 2026.
• Per Business Quant, the three latest BTAI Prepaid Assets figures stand at $3.9 million (Q1 2026), $4.0 million (Q4 2025), and $934000.0 (Q3 2025).